Schedule
7.00-7.30 Registration
7.25-7.30 Welcome & opening remarks : Banke Agarwal
Session I
7.30-9.15 Multidisciplinary management of esophageal cancers
Moderators : Gary Ratkin and Keith Naunheim
7.30-7.45 State of the art in esophageal adenocarcinoma : Gary Falk
- Results of screening, surveillance and prevention of esophageal adenocarcinoma in last 25 years
7.45-8.00
Role of a therapeutic endoscopist in the management of esophageal cancer : staging and palliation : Douglas Faigel
- EUS for staging of Esophageal cancer
- Pre-treatment staging- what information can be obtained and always be provided
- EUS restaging after chemo-XRT: its potential benefits in treatment planning
- Endoscopic stent placement:
- What is the right time in course of esophageal cancer to place stents
- Stents vs PEG for nutritional supplementation
8.00-8.15 Surgery for patients with esophageal cancer : Cameron D Wright
- Types of surgical operations available for esophageal cancer
- What are the advantages and disadvantages of each operation
- Patient selection for surgery
8.15-8.30 Advances in the management of esophageal adenocarcinoma : David Ilson
- What are the major oncologic achievements in their management
- How these have impacted patient survival and quality of life
8.30-9.15 Q&A and case studies
9.15-9.30 Coffee Break & Visit Exhibits
Session II
9.30-11.00 Innovations in endoscopic management
Moderators : Steven Fern and Steven Edmundowicz
9.30-9.45 Endoscopic ablation of mucinous cysts in pancreas : John DeWitt
9.45-10.00
EUS guided biliary drainage in patients with unresectable pancreatic tumors : Janak Shah
10.00-10.15 Trans-anal endoscopic microsurgery : Eric Lederman
10.15-10.30 Cryoablation for early esophageal cancers and Barrett’s esophagus : John Dumot
10.30-11.00Q&A
Session III
11.00 -12.00 Steps to minimize medical lawsuits
Moderators : Shaun Falvey and Erik Thyssen
Panelists : Andrew Schlafly and Jeff Segal
12.00-1.00 Lunch
Session IV
1.00-2.45 Management of Pancreatic cancer
Moderators : Todd Howard and Giuseppe Aliperti
1.00-1.15
Surgery for pancreatic cancer: Patient selection and pre-operative staging : David Linehan
- Role of pre-operative tissue diagnosis
- What is the false positive rate for malignancy when patients are operated for pancreatic cancer without tissue diagnosis
- When during surgery does the surgeon realize that there is no cancer in patients without pancreatic cancer
- Pre-operative staging work-up
- Pancreatic protocol CT
- PET scan
- Staging laparoscopy
- Patient selection: age, tumor size, vascular infiltration
- Vascular reconstruction to achieve R0 resection- Is there any survival benefit
1.15-1.30 Interventional EUS in management of patients with pancreatic cancer : Michael Levy
- Pain control with celiac plexus neurolysis
- EUS-guided injection of chemotherapeutic agents/biologic agents for treatment of pancreatic cancer
- Placement of fiducials for guided radiotherapy
1.30-1.45
Role of chemoradiation in management patients with pancreatic and biliary cancer : Margaret Tempero
- Pre-operative chemoradiation- its role in respectable and borderline resectable tumors
- Post-operative chemoradiation for pancreatic cancer. Who needs it and what does it accomplish
- Chemoradiation for locally advanced cancers- what does it accomplish
- Metastatic pancreatic cancer: role of palliative chemoradiation
- Recurrent pancreatic cancer: Does chemotherapy +/- radiation improve survival/quality of life
1.45-2.00
Determinants of survival benefit after R0 resection of pancreatic cancer : Banke Agarwal
- Influence of tumor size, peripancreatic lymp nodes, patient age and perineural tumor infiltration on survival
- Identification of subset of patients who most benefit from R0 resection of pancreatic cancer.
2.00-2.45Q&A and case studies
2.45-3.00Coffee break
Session V
3.00-4.00 Medical ethics : case studies
Moderators : Friedrich G. Schuening and Ira Kodner
Session VI
4.00-5.30 The future of colon cancer screening
Moderators : David Cort and Timothy Brady
4.00-4.15Anticipated issues in reimbursement for screening colonoscopy : Joel Brill
- RUC review of colonoscopy codes
- Carve out for sedation
- Pathology and Anesthesia
4.15-4.30
PQRI and GIQuIC and AGA Health outcomes registry: What do we need to know and how can the data so generated be leveraged for better reimbursements : Brian Jacobson
4.30-4.45Update on competing technologies for colon cancer screening : Douglas Rex
- Virtual colonoscopy, serum markers, capsule colonoscopy, other alternate colonoscopy techniques that require lower skill levels
- Are they going to compete with colonoscopy for colon cancer screening any time in near future
- What advantage does colonoscopy have on these technologies and what can we do to maintain it
